Studies showing improvements in both physical and emotional functioning and quality of life with use of C1-INH for the prevention of HAE attacks compared to placebo suggest that prophylactic treatment may be a promising strategy to manage various HRQoL deficits associated with HAE [28, 29]. Here, SERPING1 is linked to hereditary angioedema.